Anbio Biotechnology Cl A
(NNNN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | 2,373 | 2,254 | 10,011 |
| Other Working Capital | N/A | 45 | -1,204 | -5,530 |
| Other Operating Activity | 0 | -338 | -152 | -32 |
| Operating Cash Flow | $N/A | $2,080 | $898 | $4,449 |
| Cash Flows From Investing Activities | ||||
| Other Investing Activity | 0 | 337 | 1,730 | -1,528 |
| Investing Cash Flow | $N/A | $337 | $1,730 | $-1,528 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | -345 | -43 | 0 |
| Financing Cash Flow | $N/A | $-345 | $-43 | $0 |
| Beginning Cash Position | N/A | 9,688 | 7,102 | 4,181 |
| End Cash Position | N/A | 11,761 | 9,688 | 7,102 |
| Net Cash Flow | $N/A | $2,073 | $2,586 | $2,921 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | 2,080 | 898 | 4,449 |
| Free Cash Flow | 0 | 2,080 | 898 | 4,449 |